Hudson Bay Capital Management LP - 30 Sep 2025 SCHEDULE 13G/A Report for Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value (DMAA)

Filing Manager
Hudson Bay Capital Management LP
Reporting Manager
Hudson Bay Capital Management LP
Security
Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value
Symbol
DMAA
Shares outstanding
33,549,784 shares
Disclosed Ownership
1,550,000 shares
Ownership
4.6%
Form type
SCHEDULE 13G/A
Filing time
12 Nov 2025, 15:44:28 UTC
Date of event
30 Sep 2025
Previous filing
14 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Hudson Bay Capital Management LP disclosed 4.6% ownership in Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value (DMAA) on 30 Sep 2025."

Quick Takeaways

  • Hudson Bay Capital Management LP filed SCHEDULE 13G/A for Drugs Made In America Acquisition Corp. Ordinary Shares, $0.0001 par value (DMAA).
  • Disclosed ownership: 4.6%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 May 2025.
  • Current filing was accepted on 12 Nov 2025, 15:44.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Hudson Bay Capital Management LP 4.6% 1,550,000 0 1,550,000 /s/ Sander Gerber Sander Gerber, Authorized Signatory
Sander Gerber 4.6% 1,550,000 0 1,550,000 /s/ Sander Gerber Sander Gerber, Individually

Sponsored